P Peak Bio, Inc.: insider trades · United States · SEC (Form 4) Discover the full directors' dealings record of Peak Bio, Inc., a listed issuer based in United States. Shares trade on US US, under the oversight of SEC (Form 4). Market capitalisation: €1.8bn. The latest transaction was filed on 4 December 2024 (J). Among the most active insiders: Huh Hoyoung. The full history is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 4 December 2024
All Executives20 Thresholds0 Prospectus0 Other0
Declarations 20 total
● Director · Executives · 7 Oct 2024
83,800 shares 0Common Stock SEC:0000898432-24-000962:0
● Director · Executives · 14 Nov 2024
763,316 shares Common Stock SEC:0000950170-24-128153:0
● Director · Executives · 14 Nov 2024
4,574,661 shares Common Stock SEC:0000950170-24-128149:0
● Director · Executives · 14 Nov 2024
37,850 shares Common Stock SEC:0000950170-24-128150:0
167,600 shares 0Common Stock SEC:0000898432-24-000203:0
▲ See Remarks · Executives · 15 Sept 2023
11,750 shares Common Stock SEC:0000950170-23-050434:0
Ideal exit: 11 Jun 2024 (T+270) ▲ See Remarks · Executives · 26 Sept 2023
3,000 shares Common Stock SEC:0000950170-23-050436:0
Ideal exit: 22 Jun 2024 (T+270) ▲ Director · Executives · 21 Sept 2023
45,000 shares Common Stock SEC:0000950170-23-049688:0
Ideal exit: 17 Jun 2024 (T+270) ▲ Director · Executives · 19 Sept 2023
50,000 shares Common Stock SEC:0000950170-23-049173:0
Ideal exit: 15 Jun 2024 (T+270) ▲ See Remarks · Executives · 15 Sept 2023
26,000 shares Common Stock SEC:0000950170-23-048775:0
Ideal exit: 11 Jun 2024 (T+270) ▲ Director · Executives · 15 Sept 2023
25,000 shares Common Stock SEC:0000950170-23-048771:0
Ideal exit: 11 Jun 2024 (T+270) ▲ Director · Executives · 13 Sept 2023
30,000 shares Common Stock SEC:0000950170-23-048367:0
Ideal exit: 9 Jun 2024 (T+270) ▲ Director · Executives · 11 Sept 2023
30,000 shares Common Stock SEC:0000950170-23-047919:0
Ideal exit: 7 Jun 2024 (T+270) ▲ Director · Executives · 29 Aug 2023
00Common Stock SEC:0000950170-23-047707:0
Ideal exit: 25 May 2024 (T+270) ▲ Director · Executives · 29 Aug 2023
5,500 shares @ US$0.25 0.1% of flow Common Stock SEC:0000950170-23-046053:0
Ideal exit: 25 May 2024 (T+270) ● Director · Executives · 14 Aug 2023
583,333 shares @ US$0.60 34.3% of flow Common Stock SEC:0000950170-23-042830:0
● Director · Executives · 20 Jul 2023
458,333 shares @ US$0.60 26.4% of flow Common Stock SEC:0000950170-23-033840:0
● Director · Executives · 23 Jun 2023
666,667 shares @ US$0.60 39.1% of flow Common Stock SEC:0000899243-23-016550:0
◇ Director · Executives · 1 Nov 2022
1,437,500 shares 0Common Stock SEC:0000899243-22-035083:0
● Director · Executives · 1 Nov 2022
6,442,438 shares 0Common Stock SEC:0000899243-22-035081:0